ANGO vs KMB · rev $292.5M vs P/E 19, rev $20.06B
AngioDynamics Inc (ANGO) versus Kimberly-Clark Corporation (KMB) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported KMB revenue for 2024-12-31 was $20.06B. Net income was $2.58B. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
ANGO currently screens at market cap $378.5M. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
Not investment advice. Open the ANGO and KMB stock pages for the full models.
Not investment advice.